Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1891-1899

  Ometto, C ^a   Fabris, C ^a   Milanesi, C ^a   Jori, G ^a   Cook, M J ^b   Russell, D A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Photodynamic therapy; Photosensitisation; Phthalocyanine

Indexed keywords

CREMOPHOR; LOW DENSITY LIPOPROTEIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; UNCLASSIFIED DRUG; ZINC OCTADECYLPHTHALOCYANINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TARGETING; FEMALE; FIBROSARCOMA; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RAT; SKIN;

EID: 0030459124     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.650     Document Type: Article

References (45)

1. AGARWAL ML, CLAY ME, HARVEY EY, EVANS HH AND OLEINICK NL. (1991). Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res., 51, 5993-5996.
2. ALLISON BA, WATERFIELD E, RICHTER AM AND LEVY JG. (1991). The effects of plasma lipoproteins on in vitro tumour cell killing and in vivo tumour photosensitization with benzoporphyrin derivative. Photochem. Photobiol., 54, 709-715.
3. BIOLO R, JORI G, SONCIN M, PRATESI R, VANNI U, RIHTER B, KENNEY ME, RODGERS MAJ. (1994). Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine. Photochem. Photobiol., 59, 362-365.
4. BIOLO R, JORI G, SONCIN M, RIHTER B, KENNEY ME AND RODGERS MAJ. (1996). Effect of photosensitizer delivery system and irradiation parameters on the efficency of photodynamic therapy of B16 pigmented melanoma in mice. Photochem. Photobiol., 63, 224-228.
5. CHAPMAN NJ. (1986). Comparative analysis of mammalian plasma proteins. In Methods in Enzymology. Albens JJ and Segrest JP (eds) pp. 70-143. Academic Press: London.
6. COOK MJ, CHAMBRIER I, CRACKNELL SJ, MAYES DA AND RUSSELL DA. (1995). Octa-alkyl zinc phthalocyanines: potential photosensitizers for use in the photodynamic therapy of cancer. Photochem. Photobiol., 62, 542-545.
7. COOK MJ, FABRIS C, OMETTO C, MAYES DA, JORI G, McMURDO J, MILANESI C AND RUSSELL DA. (1994). Highly substituted phthalocyanine derivatives as potential photosensitizers for photodynamic therapy of tumours. In Photodynamic Therapy of Cancer, Vol. 2078. Jori G, Moan J and Star WM (eds) pp. 539-546. SPIE Proc: Bellingham.
8. CUOMO V, JORI G, RIHTER B, KENNEY ME AND RODGERS MAJ. (1991). Tumour-localizing and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine. Br. J. Cancer, 64, 93-95.
9. DOUGHERTY TJ. (1993). Photodynamic therapy. Photochem. Photobiol., 58, 895-900.
10. 2. Proc. SPIE, 1203, 118-125.
11. HAMBLIN MR AND NEWMAN EL. (1994). On the mechanism of the tumour-localizing effect in photodynamic therapy. J. Photochem. Photobiol. B: Biol., 23, 3-8.
12. HAVEL RJ, EDER HA AND BRAGDON JH. (1995). Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest., 34, 1345-1353.
13. HE XY, SIKES RA, THOMSEN S, CHUNG LW AND JACQUES SL. (1994). Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines. Photochem. Photobiol., 59, 468-473.
14. HENDERSON BW. (1990). The significance of vascular photosensitization in photodynamic therapy. In Future Directions and Applications in Photodynamic Therapy. SPIE Proceedings, Vol. 156, pp 153-166.
15. HENDERSON BW AND BELLNIER DA. (1989). Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. In Ciba Foundation Symposium 146, Photosensitizing Compounds: their Chemistry, Biology and Clinical Use. pp. 112-125. John Wiley: Chichester.
16. HENDERSON BW AND DOUGHERTY TJ. (1992). How does photodynamic therapy work? Photochem. Photobiol., 55, 145-147.
17. JORI G. (1985). Molecular and cellular mechanisms in photomedicine: porphyrins in microheterogeneous environments. In Primary Photoproccsses in Biology and Medicine. Bensasson RV, Jori G, Lane E and Truscott TG (eds) pp. 349-355. Plenum Press: New York.
18. JORI G. (1989). In vivo transport and pharmacokinetic behaviour of tumour photosensitizers. In Photosensitizing Compounds: their Chemistry, Biology and Clinical Use. pp. 78-94. John Wiley: Chichester.
19. JORI G. (1990). Photosensitized processes in vivo: proposed phototherapeutic applications. Photochem. Photobiol., 52, 439-443.
20. JORI G. (1992). Low density lipoproteins liposome delivery systems for tumour photosensitizers in vivo. In Photodynamic Therapy. Basic Principles and Clinical Applications. Henderson BW and Dougherty TJ (eds) pp. 173-186. Marcel Dekker: New York.
21. JORI G. (1995). Photodynamic therapy: basic and preclinical aspects. In CRC Handbook of Organic Photochemistry and Photobiology. Horspool WM and Song PS (eds) pp. 1379-1383. CRC Press: Boca Rton, FL, USA.
22. JORI G AND REDDI E. (1991). Second generation photosensitizers for the photodynamic therapy of tumours. In Light in Biology and Medicine, Vol. 2. Douglas RH, Moan J and Rontò G (eds) pp. 253-266, Plenum Press: London.
23. KONGSHAUG M. (1992). Distribution of tetrapyrrole photosensitizers among human plasma proteins. Int. J. Biochem., 24, 1239-1265.
24. KONGSHAUG M, CHENG LS, MOAN J AND RIMINGTON C. (1991). Interaction of Cremophor EL with human plasma. Int. J. Biochem., 23, 473-478.
25. MAZIÈRE JC, MORLIÈRE P AND SANTUS R. (1991). The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B: Biol., 8, 351-360.
26. MILANESI C, ZHOU C, BIOLO R AND JORI G. (1990). Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitized tumour necrosis. Br. J. Cancer, 61, 846-850.
27. MILANESI C, BIOLO R, JORI G AND SCHAFFNER K. (1991). Experimental photodynamic therapy with tetrapropyl-porphycene: ultrastructural studies on the mechanisms of tumour photodamage. Lasers Med. Sci., 6, 437-442.
28. MOAN J AND BERG K. (1992). Photochemotherapy of cancer: experimental research. Photochem. Photobiol., 55, 931-948.
29. PASS HI. (1993). Photodynamic therapy in oncology -mechanisms and clinical use. J. Natl Cancer Inst., 85, 443-456.
30. PENNING LC AND DUBBELMAN TMAR. (1994). Fundamentals of photodynamic therapy cellular and biochemical aspects. Anticancer Drugs, 5, 139-146.
31. REDDI E, LO CASTRO G, BIOLO R AND JORI G. (1987). Pharmacokinetic studies with Zn(II)-phthalocyanine in tumour-hearing mice. Br. J. Cancer, 56, 597-600.
32. RIS HB, ALTERMATT HJ, NACHBUR B, STEWART JCM, WANG Q, LIM CK, BONNETT R AND ALTHAUS U. (1993). Effect of drug light interval on photodynamic therapy with meta-tetrahydroxy-phenylchlorin in malignant mesothelioma. Int. J. Cancer, 53, 141-146.
33. SEGALLA A, MILANESI C, JORI G, CAPRARO HG, ISELE U AND SCHIEWECK K. (1994). CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours. Br. J. Cancer, 69, 817-825.
34. SONCIN M, POLO L, REDDI E, JORI G, KENNEY ME, CHENG G AND RODGERS MAJ. (1995a). Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxyphthalocyanines. Br. J. Cancer, 71, 727-732.
35. SONCIN M, POLO L, REDDI E, JORI G, KENNEY ME, CHENG G AND RODGERS MAJ. (1995b). Effect of the delivery system on the biodistribution of Ge(IV)-octabutoxy-phthalocyanines in tumour-bearing mice. Cancer Lett., 89, 101-106.
36. SONCIN M, POLO L, REDDI E, JORI G, RIHTER BD, KENNEY ME AND RODGERS MAJ. (1995c). Unusually high affinity of Zn(II)-tetradibenzobarrelenooctahutoxy-phthalocyanine for low-density lipoproteins in a tumour-bearing mouse. Photochem. Photobiol., 61, 310-312.
37. SPIKES JD. (1986). Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumours. Photochem. Photobiol., 43, 691-699.
38. VALLES MA, BIOLO R, BONNETT R, CANETE M, GOMEZ AM, JORI G, JUARRANZ A, MCMANUS KA, OKOLO KT, SONCIN M AND VILLANUEVA A. (1995). Benzoporphyrins as photosensitizers for the photodynamic therapy of cancer. In Photochemotherapy: Photodynamic Therapy and Other Modalities, Vol. 2625. Ehrenberg B, Jori G and Moan J (eds) pp. 11-22. SPIE Proc: Bellingham.
39. VILLANUEVA A, CAGGIARI L, JORI G AND MILANESI C. (1994). Morphological aspects of an experimental tumour photosensitized with a meso-substituted cationic porphyrin. J. Photochem. Photobiol. B: Biol., 23, 49-56.
40. WOODBURN K, CHANG KC, LEE S, HENDERSON BW AND KESSEL D. (1994). Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem. Photobiol., 60, 154-159.
41. ZAIDI SI, OLEINICK NL, ZAIN MT AND MUKTAR H. (1993). Apoptosis during photodynamic therapy-alteration of RIF-1 tumours in C3H mice; electron microscope, histopathologic and biochemical evidence. Photochem. Photobiol., 58, 771-776.
42. ZALAR GL, POH-FITZPATRICK M, KROHN DL, JACOBS R AND HARBER LC. (1977). Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin. Arch. Dermatol., 113, 1392-1397.
43. ZHOU C. (1989). Mechanisms of tumour necrosis induced by photodynamic therapy. J. Photochem. Photobiol. B: Biol., 3, 299-318.
44. ZHOU C, MILANESI C AND JORI G. (1988). An ultrastructural comparative evaluation of tumours photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. Photochem. Photobiol., 48, 487-492.
45. ZHOU C, SHUNJI C, JINSHENG D, JUNLIN L, JORI G AND MILANESI C. (1996). Apoptosis of mouse MS-2 fibrosarcoma cells induced by photodynamic therapy with Zn(II)-phthalocyanine. J. Photochem. Photobiol. B: Biol., 32, 219-223.